Expanding dementia research for Latino communities in Latin America and the US
Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat2)
This consortium combines brain scans, genetics, and social-life information to learn more about Alzheimer's and frontotemporal dementia in Latino people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11471006 on NIH RePORTER |
What this research studies
If you join, you would be part of a large, multinational effort collecting clinical tests, cognitive exams, brain imaging, and genetic samples from Latino participants. The team will add about 3,000 new participants (people with Alzheimer’s, people with frontotemporal dementia, and healthy controls) and combine those data with earlier ReDLat participants. Researchers will compare how social and economic conditions, family genetics, and brain measures shape symptoms and disease patterns across countries. The goal is to find factors that explain differences in diagnosis and disease course for Latino communities.
Who could benefit from this research
Good fit: Ideal candidates are Latino adults with Alzheimer's disease or frontotemporal dementia, their family members in large families for genetic study, and healthy Latino older adults in Argentina, Brazil, Chile, Colombia, Mexico, Peru, or the US.
Not a fit: People without Latino ancestry or those living far outside the participating countries and centers are less likely to benefit directly from this study's findings or participate.
Why it matters
Potential benefit: If successful, the work could lead to more accurate diagnoses and care approaches tailored to Latino patients with dementia.
How similar studies have performed: This builds on the earlier ReDLat effort and other dementia consortia, but is one of the largest projects focused specifically on Latino AD and FTLD populations.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Miller, Bruce L — University of California, San Francisco
- Study coordinator: Miller, Bruce L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.